Merck (MRK) Payables (2009 - 2026)

Merck (MRK) has reported Payables for 18 consecutive years, with $6.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables changed 0.2% year-over-year to $6.0 billion in Q2 2026; TTM through Jun 2026 was $6.0 billion, a 0.2% change from a year earlier, with the FY2025 full-year figure at $6.5 billion, up 6.18% from the prior year.
• Payables was $6.0 billion for Q2 2026 at Merck, down from $6.0 billion in the prior quarter.
• Over five years, Payables peaked at $6.5 billion in Q4 2025 and troughed at $5.1 billion in Q3 2022.
• A 5-year average of $5.7 billion and a median of $5.7 billion in 2023 frame the typical range for Payables.
• Across the five-year window, Payables slipped 5.56% in 2022 and rose 11.15% in 2025, its largest moves.
• Over 5 years, Payables stood at $6.1 billion in 2022, then fell by 3.92% to $5.9 billion in 2023, then increased by 4.33% to $6.2 billion in 2024, then advanced by 6.18% to $6.5 billion in 2025, then fell by 8.97% to $6.0 billion in 2026.
• The last three Payables figures came in at $6.0 billion (Q2 2026), $6.0 billion (Q1 2026), and $6.5 billion (Q4 2025), per Business Quant data.